Therapy of secondary leukemia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/2402456.pdf
Reference17 articles.
1. Andersen MK, Pedersen-Bjergaard J . Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere Leukemia 2000 14: 105–111
2. Johansson B, Mertens F, Mitelman F . Primary vs secondary neoplasia associated chromosomal balanced abnormalities – rearrangements vs genomic imbalance? Genes Chromosom Cancer 1996 16: 155–163
3. Rowley J, Golomb H, Vardiman J . Nonrandom chromosome abnormality in acute leukaemia in dysmyelopoietic syndromes in patients with previously treated malignant disease Blood 1981 58: 759–767
4. Kantarjian HM, Keating MJ, Walters RS, McCredie KB, Smith TL, Talpaz M, Beran M, Cork A, Trujillo JM, Freireich EJ . The association of specific ‘favorable’ cytogenetic abnormalities with secondary leukemia Cancer 1986 58: 924–927
5. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A . The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial Blood 1998 92: 2322–2233
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group;JCO Precision Oncology;2023-01
2. Novel mitochondria-targeting compounds selectively kill human leukemia cells;Leukemia;2022-06-07
3. DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy;Cancer Genetics;2021-04
4. Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype;Blood Cancer Journal;2020-05
5. Phase III Open-Label Randomized Study of Cytarabine in Combination With Amonafide L-Malate or Daunorubicin As Induction Therapy for Patients With Secondary Acute Myeloid Leukemia;Journal of Clinical Oncology;2015-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3